Elliptic Laboratories ASA Logo

Elliptic Laboratories ASA

ELABS.OL

(0.5)
Stock Price

10,28 NOK

-7% ROA

-7.96% ROE

-55.01x PER

Market Cap.

1.379.102.500,00 NOK

3.05% DER

0% Yield

-28.63% NPM

Elliptic Laboratories ASA Stock Analysis

Elliptic Laboratories ASA Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Elliptic Laboratories ASA Fundamental Stock Analysis
# Analysis Rating
1 DER

The stock has a low debt to equity ratio (3%), which means it has a small amount of debt compared to the ownership it holds

2 ROE

Negative ROE (-7.13%) indicates poor financial performance, raising concerns about profitability and efficiency in utilizing shareholders' equity.

3 ROA

The stock's ROA (-8.02%) suggests that it's struggling to generate profits from its assets, making it a risky choice for investment.

4 PBV

The stock's high Price-to-Book Value (P/BV) ratio (5.45x) suggests it's overvalued, potentially making it an expensive investment.

5 Revenue Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

6 Net Profit Growth

Throughout the last five years, this company's net profit has remained unchanged, indicating a lack of growth and making it a less favorable investment option.

7 Assets Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

8 Graham Number

The company's Graham number suggests that its stock price is overestimated, implying that it may not be a promising investment opportunity.

9 Dividend Growth

Investors should note the company's stagnant dividend growth over the past three years, indicating limited profitability and potentially diminishing returns.

10 Dividend

No dividends from the company in the past three years raises doubts about its profitability for shareholders.

11 Buffet Intrinsic Value

The company's stock presents a potential concern as it appears overvalued (-59) by Warren Buffett's formula, indicating that its market price exceeds its estimated intrinsic value.

Elliptic Laboratories ASA Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Elliptic Laboratories ASA Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Sell
3 RSI Hold
4 Stoch RSI Hold

Elliptic Laboratories ASA Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Elliptic Laboratories ASA Revenue
Year Revenue Growth
2017 10.694.767
2018 41.580.757 74.28%
2019 37.957.021 -9.55%
2020 30.215.044 -25.62%
2021 54.598.000 44.66%
2022 52.062.000 -4.87%
2023 87.496.000 40.5%
2023 68.321.000 -28.07%
2024 135.536.000 49.59%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Elliptic Laboratories ASA Research and Development Expenses
Year Research and Development Expenses Growth
2017 0
2018 0 0%
2019 0 0%
2020 0 0%
2021 5.703.000 100%
2022 8.141.000 29.95%
2023 0 0%
2023 11.587.000 100%
2024 14.144.000 18.08%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Elliptic Laboratories ASA General and Administrative Expenses
Year General and Administrative Expenses Growth
2017 0
2018 4.122.840 100%
2019 5.158.958 20.08%
2020 5.589.926 7.71%
2021 5.591.000 0.02%
2022 5.975.000 6.43%
2023 8.868.000 32.62%
2023 8.079.000 -9.77%
2024 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Elliptic Laboratories ASA EBITDA
Year EBITDA Growth
2017 -40.483.669
2018 -29.352.792 -37.92%
2019 -9.816.804 -199.01%
2020 -7.405.545 -32.56%
2021 -3.585.000 -106.57%
2022 -26.750.000 86.6%
2023 -19.516.000 -37.07%
2023 -46.397.000 57.94%
2024 32.043.996 244.79%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Elliptic Laboratories ASA Gross Profit
Year Gross Profit Growth
2017 -30.509.154
2018 -5.384.217 -466.64%
2019 -7.693.713 30.02%
2020 -5.650.959 -36.15%
2021 3.791.000 249.06%
2022 -10.740.000 135.3%
2023 5.208.000 306.22%
2023 -22.818.000 122.82%
2024 56.540.000 140.36%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Elliptic Laboratories ASA Net Profit
Year Net Profit Growth
2017 -34.248.808
2018 -28.120.622 -21.79%
2019 -13.256.957 -112.12%
2020 -12.510.010 -5.97%
2021 -11.214.000 -11.56%
2022 -32.999.000 66.02%
2023 -27.712.000 -19.08%
2023 -38.001.000 27.08%
2024 19.004.000 299.96%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Elliptic Laboratories ASA Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2017 0
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2023 0 0%
2024 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Elliptic Laboratories ASA Free Cashflow
Year Free Cashflow Growth
2017 -40.239.862
2018 -43.897.146 8.33%
2019 -19.143.712 -129.3%
2020 -21.780.887 12.11%
2021 -28.432.000 23.39%
2022 -36.085.000 21.21%
2023 -68.425.000 47.26%
2023 -18.004.000 -280.05%
2024 -4.635.000 -288.44%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Elliptic Laboratories ASA Operating Cashflow
Year Operating Cashflow Growth
2017 -38.869.489
2018 -35.158.019 -10.56%
2019 -8.047.177 -336.9%
2020 -6.678.217 -20.5%
2021 -10.822.000 38.29%
2022 -12.758.000 15.17%
2023 -42.812.000 70.2%
2023 -11.661.000 -267.14%
2024 3.386.000 444.39%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Elliptic Laboratories ASA Capital Expenditure
Year Capital Expenditure Growth
2017 1.370.373
2018 8.739.127 84.32%
2019 11.096.535 21.24%
2020 15.102.670 26.53%
2021 17.610.000 14.24%
2022 23.327.000 24.51%
2023 25.613.000 8.93%
2023 6.343.000 -303.8%
2024 8.021.000 20.92%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Elliptic Laboratories ASA Equity
Year Equity Growth
2017 71.858.022
2018 47.397.915 -51.61%
2019 80.032.755 40.78%
2020 188.104.091 57.45%
2021 342.769.000 45.12%
2022 325.621.000 -5.27%
2023 323.087.000 -0.78%
2023 307.108.000 -5.2%
2024 317.516.000 3.28%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Elliptic Laboratories ASA Assets
Year Assets Growth
2017 98.448.455
2018 102.240.971 3.71%
2019 139.368.073 26.64%
2020 218.722.073 36.28%
2021 371.356.000 41.1%
2022 349.324.000 -6.31%
2023 362.134.000 3.54%
2023 349.909.000 -3.49%
2024 356.478.000 1.84%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Elliptic Laboratories ASA Liabilities
Year Liabilities Growth
2017 26.590.433
2018 54.843.056 51.52%
2019 59.335.318 7.57%
2020 30.617.982 -93.79%
2021 28.587.000 -7.1%
2022 23.703.000 -20.6%
2023 39.047.000 39.3%
2023 42.801.000 8.77%
2024 38.962.000 -9.85%

Elliptic Laboratories ASA Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0.83
Net Income per Share
-0.24
Price to Earning Ratio
-55.01x
Price To Sales Ratio
15.81x
POCF Ratio
-76.84
PFCF Ratio
-29.96
Price to Book Ratio
4.33
EV to Sales
14.97
EV Over EBITDA
-51.43
EV to Operating CashFlow
-73.02
EV to FreeCashFlow
-28.35
Earnings Yield
-0.02
FreeCashFlow Yield
-0.03
Market Cap
1,38 Bil.
Enterprise Value
1,31 Bil.
Graham Number
4.03
Graham NetNet
1.21

Income Statement Metrics

Net Income per Share
-0.24
Income Quality
0.67
ROE
-0.08
Return On Assets
-0.07
Return On Capital Employed
-0.1
Net Income per EBT
0.8
EBT Per Ebit
0.98
Ebit per Revenue
-0.37
Effective Tax Rate
0.2

Margins

Sales, General, & Administrative to Revenue
0.07
Research & Developement to Revenue
0.15
Stock Based Compensation to Revenue
0.06
Gross Profit Margin
-0.02
Operating Profit Margin
-0.37
Pretax Profit Margin
-0.36
Net Profit Margin
-0.29

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-0.17
Free CashFlow per Share
-0.44
Capex to Operating CashFlow
-1.58
Capex to Revenue
0.32
Capex to Depreciation
3.22
Return on Invested Capital
-0.08
Return on Tangible Assets
-0.07
Days Sales Outstanding
386.92
Days Payables Outstanding
26.06
Days of Inventory on Hand
0
Receivables Turnover
0.94
Payables Turnover
14.01
Inventory Turnover
0
Capex per Share
0.27

Balance Sheet

Cash per Share
0,92
Book Value per Share
3,03
Tangible Book Value per Share
3.03
Shareholders Equity per Share
3.03
Interest Debt per Share
0.12
Debt to Equity
0.03
Debt to Assets
0.03
Net Debt to EBITDA
2.92
Current Ratio
7.36
Tangible Asset Value
0,32 Bil.
Net Current Asset Value
0,15 Bil.
Invested Capital
182087000
Working Capital
0,16 Bil.
Intangibles to Total Assets
0
Average Receivables
0,09 Bil.
Average Payables
0,01 Bil.
Average Inventory
0
Debt to Market Cap
0.01

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Elliptic Laboratories ASA Dividends
Year Dividends Growth

Elliptic Laboratories ASA Profile

About Elliptic Laboratories ASA

Elliptic Laboratories ASA, an artificial intelligence (AI) software company, provides AI virtual smart sensors for the smartphone, laptop, Internet of Things, and automotive industries. The company offers AI Virtual Presence Sensor, a presence-detection solution used to improve the security of data stored on laptops; AI Virtual Proximity Sensor that enables exquisite full-screen devices; 3D touchless gesture support service; AI Virtual Gesture Sensor, a touch-free ultrasound gesture technology; AI Virtual Presence Sensor, which delivers presence-sensing capabilities to various devices that possesses a speaker, microphone, and audio processor; and AI Virtual Connection Sensor that allows to pair and authenticate smart devices in the same room. It serves in Norway, China, Taiwan, South Korea, the United States, and Japan. The company was incorporated in 2006 and is headquartered in Oslo, Norway.

CEO
Ms. Laila B. Danielsen
Employee
85
Address
Akersgata 32
Oslo, 0180

Elliptic Laboratories ASA Executives & BODs

Elliptic Laboratories ASA Executives & BODs
# Name Age
1 Mathias Norderud
Senior Financial Manager
70
2 Ms. Laila B. Danielsen
Co-Founder, President & Chief Executive Officer
70
3 Mr. Lars Holmoy
Chief Financial Officer & Investor Relations
70
4 Mr. Brian Daly
Executive Vice President of Sales & Business Development
70
5 Mr. Espen Klovning
Executive Vice-President of Engineering
70
6 Dr. Tobias Dahl
Founder
70
7 Ms. Bente Høgnes
Finance Director
70
8 Mr. Ola Sandstad
Senior Vice President of Product Development
70
9 Mr. Nilesh Shah
Senior Vice President of Client AI Architecture
70

Elliptic Laboratories ASA Competitors

poLight ASA Logo
poLight ASA

PLT.OL

(1.0)
Quantafuel ASA Logo
Quantafuel ASA

QFUEL.OL

(1.2)
Everfuel A/S Logo
Everfuel A/S

EFUEL.OL

(1.5)